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Background: Considerable efforts are being extended to develop more effective methods to detect drugs in
forensic science for applications such as preventing doping in sport. The aim of this study was to develop a
sensitive and accurate method for analytes of forensic and toxicological nature in human hair at sub-pg levels.
Results: The hair test covers a range of different classes of drugs and metabolites of forensic and toxicological
nature including selected anabolic steroids, cocaine, amphetamines, cannabinoids, opiates, bronchodilators,
phencyclidine and ketamine. For extraction purposes, the hair samples were decontaminated using dichloromethane,
ground and treated with 1 M sodium hydroxide and neutralised with hydrochloric acid and phosphate buffer and
the homogenate was later extracted with hexane using liquid-liquid extraction (LLE). Following extraction from hair
samples, drug-screening employed liquid chromatography coupled to tandem mass spectrometric (LC-MS/MS) analysis
using dynamic multiple reaction monitoring (DYN-MRM) method using proprietary software. The screening method
(for > 200 drugs/metabolites) was calibrated with a tailored drug mixture and was validated for 20 selected drugs for
this study. Using standard additions to hair sample extracts, validation was in line with FDA guidance. A Zorbax Eclipse
plus C18 (2.1 mm internal diameter × 100 mm length × 1.8 μm particle size) column was used for analysis. Total
instrument run time was 8 minutes with no noted matrix interferences. The LOD of compounds ranged between
0.05-0.5 pg/mg of hair. 233 human hair samples were screened using this new method and samples were confirmed
positive for 20 different drugs, mainly steroids and drugs of abuse.
Conclusions: This is the first report of the application of this proprietary system to investigate the presence of drugs in
human hair samples. The method is selective, sensitive and robust for the screening and confirmation of multiple
drugs in a single analysis and has potential as a very useful tool for the analysis of large array of controlled substances
and drugs of abuse.
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Hair testing is a convenient, tamper resistant and non-
invasive technique for the analysis of many controlled
drugs and drugs of abuse as compared to blood tests
and urinalysis [1]. Hair testing can be used to screen for
the parent drug and for metabolites and could be used
to complement urinalysis [1-5]. In addition to urine
tests, for the past three decades hair analysis has been
employed to detect chronic social drug use and in the* Correspondence: D.Naughton@kingston.ac.uk
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reproduction in any medium, provided the ofight against doping in sport. Longer term histories of
drug use can be detected as hair grows by approximately
1 cm per month [6-8]. Hair analysis provides a wider win-
dow of detection thus hair samples of a few centimetre
lengths will provide more accurate information of drug
use than blood and urine and it has good potential for out
of competition doping [9-12]. Most controlled drugs and
drugs of abuse are integrated into the hair matrix in a
number of ways: (i) an endogenous-exogenous pathway;
transfer or absorption of drug molecules into hair duct in
the form of sweat and sebum from transdermal secretion,
or (ii) by an endogenous pathway; the drug molecules
diffuse into growing hair from circulatory system usingn Open Access article distributed under the terms of the Creative Commons
org/licenses/by/4.0), which permits unrestricted use, distribution, and
riginal work is properly credited.
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chemical properties and pharmacokinetics also affect the
process of drug incorporation into the hair matrix. The
concentration of drug detected in hair is also influenced
by an individual’s metabolic pathway, cosmetic treatments
and hair pigmentation. Hair also favours the incorporation
of undissociated basic drugs due to carrying no net charge
due to an isoelectric pH of about 6. Furthermore, due to
the less polar nature of the parent drugs, its incorporation
into the keratin matrix is favoured in contrast to their
metabolites. While in urine it is the other way around and
relatively low concentrations of parent drugs are excreted
in urine as compared to their metabolites [18,19].
Doping in sport both in and out of competition is a
persistent problem and therefore it is highly desirable to
have a high throughput multi-analyte mass spectrometry
method for the detection of controlled drugs and drugs
of abuse in hair. Gas chromatography–mass spectrometry
(GC-MS), requires additional derivatisation and lacks the
required sensitivity to simultaneously detect large num-
bers of drugs in hair samples. Liquid chromatography-
mass spectrometry (LC-MS/MS) when used in Multiple
Reaction Monitoring (MRM) mode has been a powerful
tool for detecting and confirming the presence of drugs in
complex biological matrices. Recently, researchers have
reported the hybrid triple-quadrupole mass spectrometer
(QTrap) to screen and confirm 300, 100 and 88 drugs in
human blood samples, respectively [20-26]. While others
reported a 3200 Q Trap(R) LC-MS/MS system for analysis
of 700 and 301 drugs in serum and urine samples [27,28].
A set of over 500 negative-ion MS–MS spectra was
collected from three libraries applied in screening and
systematic toxicological analysis is also reported [29].
Moreover, the mass spectra characteristics of more than
2,500 illegal drugs and metabolites have also been mea-
sured in urine and plasma using hybrid quadrupole time-
of-flight mass spectrometry (LC-QTOF-MS) [30,31]. All
of the above techniques are limited to human blood or
urine samples. Furthermore, the LOD for most of these
drugs were not suitable for doping control purpose as
the methods of detections were not sensitive enough.
However, there is an analytical method of metabolomic
approach used for hair analysis using time of flight
detector (TOF) and High resolution mass spectrometry
(HRMS), which is limited to metabolite analysis and not
the actual compounds and hence not widely used [32,33].
An UPLC-TOF-MS method for simultaneous screening
and quantification of 52 drugs in hair was also developed
and validated but the analysis of drugs were limited and
only 15 autopsy hair samples were tested using this
method [34].
The aim of this paper was (i) to develop a hair-based
multi-drug/metabolite assay using LC-MS/MS with a
dynamic multiple reaction monitoring (DYN-MRM)[35,36] method using a proprietary software, for both
screening and validated confirmatory analyses, and (ii) to
apply the method to hair samples for drugs and metabo-
lites relevant to social drug use and doping in sport.
Materials and methods
Reagents and chemicals
LC/MS grade acetonitrile and deionised water together with
formic acid, ammonium formate, dichloromethane, sodium
hydroxide, hydrochloric acid, pentane, sodium hydrogen
phosphate heptahydrate, and sodium phosphate monobasic
dihydrate were obtained from Sigma-Aldrich (Poole-Dorset,
UK). All drugs including nandrolone, stanozolol, testosterone,
boldenone, cocaine, benzoylecgonine, cocaethylene, amphet-
amine, n-desmethyselegiline, ephedrine, methamphetamine,
3,4-methylenedioxy-N-methylamphetamine (MDMA), 3,4-
methylenedioxyamphetamine (MDA), tetrahydrocannabinol
(THC), 11-hydroxy-THC (11-OH-THC), THC-carboxylic
acid-(THC-COOH), ketamine, norketamine, clenbuterol,
propranolol, terbutaline, salbutamol, morphine, codeine
and phencyclidine (PCP) together with internal standards
stanozolol-d3, cocaine-d3, MDMA-d5, THC-d3, codeine-
d3, ketamine-d4 and PCP-d5 were all purchased from LGC
standards (Teddington, UK).
Calibrant and stock solutions
Stock solutions of individual analytes and internal stan-
dards were prepared by dissolving or diluting it in metha-
nol obtaining a concentration of 1 mg/mL. Individual
stock solutions were diluted to prepare a standard mixture
solution by mixing individual drug in methanol arriving at
a concentration of 1 μg/mL. Moreover, working solutions
of the individual standards were also prepared in metha-
nol at various concentrations. The concentration of the
working solution of internal standards mixture used was
10 ng/mL. Calibrants and quality control samples were
prepared using blank hair. All standard stock solutions
of forensic and toxicological interest were prepared in
methanol at a concentration of 1 mg/mL. Furthermore,
a bespoke working solution test mixture was prepared
from dilution of stock solutions in-house at a concen-
tration of 10 ng/mL. The test mix prepared, consisted of
a representative range of forensic analyte classes of 27
components which is used to check the sensitivity and
accuracy of the new dynamic MRM assay. All solutions
were stored in amber plastic tubes at −80°C until further
analysis.
Sample preparation and analysis
Hair samples (50 mg) were collected from 233 volunteers
as part of a research project investigating the discri-
minatory power of drug- and doping-related explicit and
implicit social cognitive measurements in behavioural
context indexed on the presence or absence of the target
Table 1 Chromatogarphic and spectrometric








Nandrolone 275.1 257 105 5
109.1 21
Stanozolol 329.1 175.2 105 10
107.1 34
Boldenone 287.2 135.1 105 5
121.1 20
Cocaine 304.2 182.1 138 17
77 61
Benzoylecgonine 290.1 168.1 118 17
77 60
Amphetamine 136.1 119.1 66 5
91 17
Methamphetamine 150.1 91 92 17
65.1 45
Ephedrine 166.1 148.1 81 9
115 25
MDMA 194.1 163 97 9
105 25
THC 315.2 123.3 150 30
193.2 20
THC-COOH 345.2 299.2 140 18
327.2 18
11-Hydroxy THC 331.2 313.2 112 9
193.1 21
Morphine 286.2 165.1 158 41
152 60
Codeine 300.2 165.1 158 45
58.1 29
Clenbuterol 277 203.1 100 15
240 166 90 15
Propranolol 260 115.9 110 22
Salbutamol 240 73.9 90 22
Terbutaline 226.2 125.1 100 20
152.1 20
PCP 244.2 91 86 41
86.1 9
Ketamine 238.1 220.1 105 11
125 11
Shah et al. Chemistry Central Journal 2014, 8:73 Page 3 of 10
http://journal.chemistrycentral.com/content/8/1/73drugs in hair. On the average the hair samples were 3 cm
in length (circa 120 mg in weight). The hair samples were
cut directly from the vertex posterior of the head where it
was possible. The hair samples were stored in labelled,
sealed paper envelopes. The study was approved by the
Kingston University Research Ethics Committee. Blank
hair samples were obtained from healthy volunteers with
no previous drugs use.
Extraction of hair samples and screening using dynamic
MRM-LC-MS/MS mode
The Agilent Technologies forensic and toxicology dy-
namic MRM-LC-MS/MS kit was used to screen hair
samples for all controlled substances and drugs of abuse
of interest by employing a single point calibration curve.
For extraction, the hair samples were decontaminated
using dichloromethane then milled in a mini ball mill
(Fritsch and Gerhardt UK Ltd); 20 mg hair was weighed
out and incubated with 1 M sodium hydroxide at 95°C
for 5 minutes. The mixture was neutralised with 1 M
hydrochloric acid followed by addition of 2 mL of 0.2 M
phosphate buffer pH 7 [6]. The sample was further ex-
tracted using hexane and 2 μL injected on to the LC-
MS/MS system. The kit was found to be a good and
convenient starting point for the screening of a large
array of toxicological and forensic analytes. As compared
to the multiple reactions monitoring (MRM), dynamic
MRM has an associated delta retention time window
(Del RT) where it dynamically turns on and off without
affecting the total cycle time. But some time compromises
between, cycle time, dwell time and the total number of
MRM transitions are required in a large number of ana-
lytes screening assays. For screening purposes we have
used mostly 4 MRM transitions for each compound.
Confirmation of extracted hair samples
For quantitative confirmatory analysis of positive hair
samples a 6–8 point calibration curve was used along with
quality control samples. A further 2 μL of extracted hair
sample was injected for quantitative analysis using DYN-
MRM-LC-MS/MS. Only the two most abundant MRM
transitions were used for confirmatory analysis. Of the
two, the most sensitive transition was used as quantifier
ions and the other transition as qualifier ions, the ratios of
which are indicative of the analyte of interest.
Instrumentation
The LC–MS/MS system comprised of a 1260 infinity LC
system (Agilent Technologies UK) coupled to a 6430 triple
quadrupole mass spectrometer (Agilent Technologies UK).
The LC system consisted of a 1290 infinity thermo-stated
autosampler, degasser, binary pump and column heater.
Agilent Masshunter Forensics and Toxicology dyna-
mic MRM software kit was used in combination withMasshunter workstation software. An electrospray ionisa-
tion (ESI) source was employed for samples ionisation.
The chromatographic separation was achieved using a
Zorbax Eclipse plus C18 (2.1 mm × 100 mm, 1.8 μm)
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bility. The analytical column was connected in tandem
with a 0.2 μm inline filter to prevent it from blocking. Mo-
bile phase consisted of a Solvent A [10 mM ammonium
formate/0.02 M formic acid in water] and solvent B
[0.02 M formic acid in acetonitrile].
The flow rate through the column was set at 0.4 mL/
min. The gradient flow composition is described as fol-
lows. The mobile phase linear gradient was run with
90% solvent A for 0.5 minutes and 10% solvent B, de-
creasing to 50% solvent A in 3 minutes, decreasing fur-
ther to 5% solvent A and 95% solvent B, and held from 4
to 6 minutes and then returned to 90% of solvent A until
7 minutes, and stabilised until 8 minutes before next
injection. The bypass configurations were set up for the
mixer and damper when using this kit with our Agilent
HPLC 1260 binary pump. This was to convert the pump
to low delay volume mode to achieve better chromatog-
raphy. The mass spectrometer was operated in positive
ionization polarity at a spray capillary voltage of 3000 V.
Sheath gas temperature and fow was 350°C, 12 L/min,
nozzle voltage was 450 V, drying gas temperature and
flow 300°C, 8 L/min, nebulizer gas pressure was 25 psi
and fragmentor voltage was set to 150 V, Delta retention
time was 1 for all ions in dynamic MRM mode. The totalFigure 1 Chromatogram showing peaks for 27 spiked drugs in a sing
peak elution times).run time was 8 min together with 2 min post time
equilibration. The acquired dynamic MRM transitions,
fragmentor voltages and collision energies of quantified
analyte are given in Table 1 [36].
Method validation
Given the necessity to adopt tailored test mixtures based
on the drug profile of interest it was necessary to validate
the methods for confirmation of positive drugs. Repeated
injections (n = 6) were performed on a single day to estab-
lish the intra-day precision (% CV), while the inter-day
precision was evaluated on several days. The accuracy was
expressed as the ratio of the compound added to the mea-
sured (mean value/nominal value) × 100. Extraction effi-
ciency of the compounds was determined by spiking
blank hair samples with 10 pg/mg drugs. Absolute recov-
eries were determined by comparing the concentrations
obtained from peak height ratios of extracted hair samples
with added concentrations (standard addition method was
used for the analysis of testosterone). Relative recoveries
were determined by comparing the % amount of drug
recovered from hair matrix against detector response for
extracted standards, utilising three different concentra-
tions of quality controls. Stability checks were performed
by carrying out three freeze/thaw cycles (between roomle extract of human hair using DYN-MRM-LC-MS/MS. (See text for
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blank hair with three different concentrations of quality
controls (10, 25 and 50 pg/mg).
Results and discussion
The MassHunter Forensics and Toxicology Dynamic
MRM Database Kit was able to screen for 300 analytes
of Forensics and Toxicology nature with enhanced sensi-
tivity, all in a single LC/MS analytical run. The Kit also
helped to minimize method development for this analysis.
The kit came equipped with, MRM transitions for analytes
of forensics and toxicological nature along with their opti-
mized fragmentor voltages and collision energy settings.
During method development, these MRM transitions
were imported from the database to the MassHunter Data
Acquisition program where these transitions were used
for screening and confirmation purpose. These MRM
transitions were also compared against MRM transitions
for infused analytes. The Dynamic MRM feature of
Agilent Triple Quadrupole mass spectrometer provided
us with an adaptive MRM data collection methodologyFigure 2 DYN-MRM-LC-MS/MS chromatogram showing delta retentio
single extract of human hair sample. From top: terbutaline, ephedrine, m
stanozolol-d3, THC acid and cannabidiol (THC).where the instrument was able to collect data only during
a predetermined time window. The advantage is that more
than one compound/MRMs can be analyzed in a single
run through the Dynamic MRM feature, without losing
data quality. The Agilent MassHunter software was used
for data generation. Table 1 shows the precursor and
product ions of the confirmed analytes along with their
fragmentor voltages and collision energies. The proton-
ated molecules [M +H]+ was identified as the precursor
ions and the diagnostic product ions were monitored in
dynamic multiple reactions monitoring (MRM) mode.
Dynamic MS/MS transitions for the LC/MS Forensics
and Toxicology test mixture and their chromatographic
evaluation could not be achieved because of the un-
availability of this kit in the UK, and due to Home office
licensing restrictions in the UK. The commercially avail-
able standard Dyn-MRM kit mixture was comprised of
about 24 drugs (codeine, oxycodone, amphetamine, me-
thamphetamine, MDA, MDMA, MDEA, hydrocodone,
strychnine, cocaine, heroin, meperidine, trazodone, PCP,
oxazepam, nitrazepam, verapamil, methadone, lorazepam,n time (Del RT,Δt) window for 10 spiked drugs of abuse in a
ethamphetamine, benzoylecgonine, clenbuterol, THC-d3, boldenone,
Table 2 Summary of assay validation results




LOD r2 Inra-day (n = 6) Inter-day(n = 6)
Precision, % CV Accuracy,% Precision, % CV Accuracy,%
Nandrolone 10 0.1-100 0.05 0.9998 3.23 100.1 4.82 99.8
25 1.96 100.4 1.95 99.4
50 1.41 99.9 1.39 100.2
Stanozolol 10 0.1-100 0.05 0.9995 6.3 102.1 9.4 101.2
25 10.2 98.5 7.1 99.8
50 8.6 99.4 3.2 101.3
Boldenone 10 0.5-100 0.25 0.9998 4.9 99.9 3.4 101.1
25 3.3 100.3 2.7 99.8
50 2.5 99.7 2.3 98.7
Cocaine 10 0.5-100 0.25 0.9998 3.5 98.9 3.2 99.8
25 4.3 99.4 3.3 98.9
50 2.9 99.9 2.3 97.8
Benzoylecgonine 10 0.5-100 0.25 0.9987 3.5 107.2 4.7 100.5
25 2.1 102.3 10.9 102.6
50 3.3 100.1 8.9 99.9
Amphetamine 10 0.25-100 0.1 0.9979 7.1 98.8 3.2 100.5
25 5.9 99.6 2.7 100.1
50 3.2 89.9 3.2 100.3
Methamphetamine 10 0.5-100 0.25 0.9988 5.2 98.3 5.3 100.2
25 2.3 102.6 2.1 103.3
50 4.1 100.9 3.6 108.1
Ephedrine 10 1-100 0.5 0.9945 3.8 99.3 4.3 101.2
25 3.5 98.7 2.1 99.8
50 3.2 101.2 3.2 99.9
MDMA 10 0.5-100 0.25 0.9968 5.1 99.4 5.1 100.3
25 2.4 103.2 3.3 110.2
50 3.7 101.6 6.2 104.2
THC 10 1-100 0.5 0.9996 2.1 107.3 4.3 109.2
25 3.2 110.2 2.6 105.3
50 5.1 101.3 3.9 103.2
THC-COOH 10 1-100 0.5 0.9992 4.3 100.1 3.3 101.1
25 3.6 98.9 3.9 99.9
50 2.9 98.6 4.3 98.9
11-OH-THC 10 0.5-100 0.25 0.9998 3.6 89.8 5.3 90.5
25 2.1 89.9 5.9 89.6
50 5.3 90.9 2.1 99.8
Morphine 10 0.5-100 0.25 0.999 4.2 89.3 3.2 90.9
25 6.3 88.9 5.3 91.8
50 3.9 100.9 2.1 99.5
Codeine 10 0.5-100 0.25 0.999 2.9 98.9 1.9 99.5
25 8.3 99.5 5.6 99.3
50 2.4 99.3 1.5 9.8
Shah et al. Chemistry Central Journal 2014, 8:73 Page 6 of 10
http://journal.chemistrycentral.com/content/8/1/73
Table 2 Summary of assay validation results (Continued)
Clenbuterol 10 0.5-100 0.25 0.9989 5.1 114.2 4.6 104.3
25 2.1 89.9 1.3 103.4
50 1.2 99.9 1.3 105.6
Salbutamol 10 1-100 0.5 0.9998 2.1 99.9 1.9 102.3
25 1.9 98.4 1.8 101.2
50 3.2 100.5 2.1 101.1
Propranolol 10 0.1-100 0.05 0.9999 2.2 99.7 1.9 100.5
25 2.6 89.9 2.5 99.78
50 1.1 98.9 1.5 98.5
Terbutaline 10 0.5-100 0.25 0.9997 1.7 100.8 1.9 99.9
25 1.2 99.9 2.1 100.5
50 2.2 100.5 1.9 102.3
PCP 10 0.5-100 0.25 0.9998 1.4 102.3 2 100.3
25 2.1 101.3 3.5 100.1
50 3.2 105.1 1.5 100.5
Ketamine 10 0.5-100 0.25 0.9996 1.6 104.2 1.1 98.9
25 2.6 102.3 2.1 99.9
50 2.4 104.2 2.2 99.6
Table 3 The quantitative range and frequency of
occurrence of confirmed drugs in human hair
Drugs Frequency of
occurrences
Range of drugs found
in hair (pg/mg)
Nandrolone 5 0.12 − 15.28
Stanozolol 14 0.36 − 8.24
Boldenone 1 1.4
Testosterone 233 1.19 − 4.1
Naltrexone 2 8.6 − 16.6
Cocaine 4 1.2 − 10.3
Benzoylecgonine 1 4.4
Amphetamine 6 0.28 − 13.6
Methamphetamine 3 0.884 − 5.6
Ephedrine 1 5.4
MDMA 2 8.6 − 8.76
THC 9 1.2 − 8.4
THC-COOH 1 18.2
11-OH-THC 8 0.61 − 3.1
Morphine 4 1.9 − 10.8
Codeine 5 3.4 − 8.3
Clenbuterol 7 0.95 − 9.2
Salbutamol 7 1 − 12.52
Propranolol 3 1.12 − 12.4
Terbutaline 3 0.79 − 1.8
PCP 4 0.89 − 1.13
Ketamine 4 1.3 − 9.6
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Because of its unavailability in UK, we had to tailor make a
test mixture which consisted of the following 21 drugs of
interest along with 6 internal standards (nandrolone, stano-
zolol, boldenone, testosterone, cocaine, benzoylecgonine,
amphetamine, methamphetamine, ephedrine, MDMA,
THC, THC-COOH, 11-hydroxy THC , morphine, co-
deine, clenbuterol, salbutamol, propanolol, terbutaline,
PCP, ketamine and internal standards like stanozolol-d3,
amphetamine-d5, methamphetamine-d5, MDMA-d5,
THC-d3 and cocaine-d3). The chromatogram in Figure 1
shows the standard mixture of 27 drugs spiked in human
hair extracted and analysed using DYN-MRM-LC-MS/MS
method.
The retention times of 21 spiked drugs along with
their 6 internal standards in human hair, along with 6
internal standards spiked in human hair where delta
retention time was 1, are as follows: Peaks =Morphine
(0.71 min), terbutaline (0.75), amphetamine-d5 (1.67), am-
phetamine (1.67), methamphetamine (1.76), methampheta-
mine-d5 (1.76), MDMA (1.92), 5-MDMA (1.92), ketamine
(2.3), benzoylecgonine (2.67), clenbuterol (2.73), cocaine
(2.98), cocaine-d3 (2.98), boldenone (3.22), THC (3.35),
THC-d3 (3.35), nandrolone (3.4), PCP (3.5), codeine
(3.54), ephedrine (3.71), salbutamol (3.95), propranolol
(4.32), testosterone (4.7), stanozolol (4.81), stanazolol-d3
(4.81),THC acid (5.29), 11-hydroxy THC (5.3). The Delta
retention time for all analytes was 1.
The following representative chromatogram (Figure 2)
shows the importance of the short retention time windows
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time. In this example, ten drugs were spiked into a hair
sample, extracted and analysed using DYN-MRM-LC-
MS/MS method.
Validation results
Intra-day and inter-day precision and accuracy are shown
in Table 2. Drug free blank hair was analysed to evaluate
the specificity of analytical method. Endogenous drugs
(e.g. testosterone) solutions were prepared in human
hair samples using the standard additions method. The
absolute recoveries of the analytes and internal standards
were ranging from 98.2 to 98.7% and 94.3 to 99.6%,
respectively. Relative recoveries for analytes and internal
standards ranged from 99.8 to 102.2% and 99.8 to 99.9%
respectively. In the Table, r2 represents the linear regres-
sion; all the units are represented in pg/mg units. The
assay showed excellent sensitivity (LOD = 0.1 pg) and
linearity. Where limit of quantitation ranged between
0.1-1 pg/mg. Calibration linearity was not less than
(R2 = 0.9987) for the spiked analytes.
Application in hair-analysis
For this study the analysis results of 233 hair samples
showed that about 70 volunteers were confirmed positive
for some of 20 different of drugs of forensic nature, mainlyFigure 3 Mean concentrations of analytes along with the frequency of
standard deviation.steroids and drugs of abuse. Out of these 70 only one vol-
unteer was positive for 5 drugs, 2 volunteers were positive
for four different drugs and 11 volunteers were positive for
2 drugs at the same time. The rest of the 56 volunteers
were positive for 1 drug each. The range of drugs found in
hair and their frequencies are given in Table 3 and Figure 3.
Benefits of dynamic-MRM over MRM technique
Multiple reactions monitoring (MRM) mode has been
widely used as a suitable way of conducting quantitative
analysis using triple quadrupole mass spectrometry, but
the limitation of this method is the use of a series of
time segments to monitor MRM transitions. In order to
analyse very low quantities of hundreds of compounds
of forensic and toxicological nature, in a wide variety of
matrices, dynamic MRM is useful. Dynamic MRM me-
thod development and modifications are a lot easier and
more reliable and provide better quality data compared
to traditional time segments in MRM mode. A further
benefit of this method is that, rather than performing
scans for all the analytes during the entire method, the
mass spectrometer only monitors MRM transitions for
the analytes that elute in that particular time segment.
The result is that there are fewer transitions recorded
during each MS scan, allowing the mass spectrometer to
use a longer dwell time and more data points per peak.positive occurrences (shown in brackets). The error bars represents
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are eluting from the LC to focus detection. This approach
also allows total exclusion of background and inter-
ferences problems. These qualities made it possible to use
dynamic MRM mode to screen for about 20 drugs of
forensic and toxicological nature in hair samples just over
8 minute time period. Since a quantifier ion and a qualifier
ion were necessary for confirmatory purposes, a total
of about 40 dynamic MRM transitions were employed
during the analysis, covering classes of analytes such
as steroids, amphetamines, cannabinoids, cocaine’s and
bronchodilators etc.Advantages of hair-dynamic MRM drug analyses method
This study reports the application of a hair-based multi-
drug analytical approach which has high sensitivity and
accuracy and is capable of analysisng some 200 drugs/me-
tabolites in one chromatographic run. The benefits of the
novel method over current approaches include: i) long-
term such as quarterly detection windows (for 3 cm hair
samples) and ease of ‘non-invasive hair’ collection, reduced
infection risk and storage demands, ii) using Dyn-MRM
software affords the ability to screen for some 200 com-
pounds of interest simultaneously in one chromatographic
run (i.e. 8 min) using a test mixture to calibrate the LC
component, iii) develop a full validation for compounds of
interest and thus perform full confirmation analysis, iv)
adapt the software to add new compounds of interest.
It should be noted that the focus of this study was on
the range of drugs and their metabolites listed. For this
reason the calibrant test mixture was prepared and valid-
ation steps were completed with these selected com-
pounds. The method also allows screening for any of the
other 200 plus drugs/metabolites from spectral library and
full validation can be added using reference and standard
material.Conclusion
This study reports the development and validation of a
method to analyse drugs of forensic and toxicological
nature in human hair samples. The method is selective,
sensitive and robust for the screening and confirmation of
multiple drugs in a single analysis and will be very useful
tool for the analysis of large array of controlled substances
and drugs of abuse. This is the first report of the appli-
cation of this proprietary system to drugs of abuse in hair
samples. In this example, it employs the Dyn-MRM soft-
ware to screen and confirm for 20 selected analytes (via
full validation) of forensic interest present in the hair
samples in a single chromatographic run.
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